PO-1194: MR-based adaptive IGRT of prostate cancer: feasibility, plan adaptation and acute toxicity. (November 2020) - Wegener, D.; Paulsen, F.; De Colle, C.; Thorwart, D.; Grosse, U.; Othman, A.; Afat, S.; Bedke, J.; Stenzl, A.; Nikolaou, K.; Zips, D.; Müller, A.